The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant chemotherapy (CT) benefit in invasive lobular carcinoma (ILC) by Oncotype DX Recurrence Score and menopausal status.
 
Arya Mariam Roy
No Relationships to Disclose
 
Yevgeniya Gokun
No Relationships to Disclose
 
Brandon Slover
No Relationships to Disclose
 
Nerea Lopetegui-Lia
Honoraria - Aptitude Health; Curio Science; OncLive/MJH Life Sciences; Primum
Consulting or Advisory Role - Stemline Therapeutics
 
Dionisia Quiroga
Honoraria - Cardinal Health
 
Kai Johnson
No Relationships to Disclose
 
Gilbert Bader
No Relationships to Disclose
 
Ashley Davenport
No Relationships to Disclose
 
Sagar Sardesai
No Relationships to Disclose
 
Robert Wesolowski
Consulting or Advisory Role - BioNTech SE; Celcuity; Celcuity; Lilly; Medison; Pfizer; Signatera
Other Relationship - Merck
 
Sara Myers
No Relationships to Disclose
 
Erin Burke
No Relationships to Disclose
 
Annapurna Gupta
No Relationships to Disclose
 
Sarmila Majumder
No Relationships to Disclose
 
Margaret Gatti-Mays
Research Funding - Marengo Therapeutics (Inst); Sumitomo Pharma Oncology
 
Nicole Williams
No Relationships to Disclose
 
Daniel Stover
Consulting or Advisory Role - AstraZeneca; Guardant Health; IQvia; Natera; Precede Bio
Research Funding - Foundation Medicine (Inst); NeoGenomics Laboratories (Inst)
Patents, Royalties, Other Intellectual Property - Intellectual Property Related to Cancer Diagnostics